Report: Alex Rodriguez Tested Positive For Stimulants In 2006
The New York Times has a massive story on the ugliness of Alex Rodriguez's arbitration hearing, and as you might expect, everyone comes out looking bad. Sex! Bribes! Leaks-a plenty! But your headline-ready revelation is that Alex Rodriguez tested positive for a banned stimulant in 2006, according to the Times' sources.
The failed 2006 test was not revealed (and still should not have been revealed) because according to the CBA, a first positive is kept confidential, with no punishment handed down. But as with all the leaks in the A-Rod saga, more fun can be had figuring out who's gabbing to the press and why.
Rodriguez is obviously convinced MLB's behind this latest disclosure, and today his attorneys filed an official complaint accusing baseball of smearing him ahead of the arbitrator's decision. An MLB source—excuse me, a source that may or may not be in MLB—asked the Daily News a stupid rhetorical question:
"All it would do," said the source, "is make it look to the arbitrator like baseball is desperate to out Rodriguez. Why would they do that?"
Yeah! What could MLB, whose entire case is built around painting Rodriguez as a habitual, recidivist PED user, ever hope to gain by making it known that A-Rod failed a drug test?
Anyway, A-Rod vs. MLB is basically the Cardinals-Red Sox of arbitration hearings. Go meteor!
NBA Best Bets: Expert Picks for Tuesday’s Playoff Action
Top Remaining Veterans Teams Should Target After NFL Draft
Why Top NBA Draft Prospects Aren’t Guaranteed Stars
Top Quarterbacks to Watch for the 2027 NFL Draft
- UFC Vegas 116 Best Bets: Full Card Picks, Props, and Betting Predictions
- Best Betting Picks for Saturday’s NBA Playoff Matchups
- Friday NBA Picks & Predictions: Best Bets for April 24 Playoff Slate
- MLB Best Bets Today: Strikeout Props and Total Plays to Target
- NBA Playoffs Betting Picks: Game 3 Predictions & Best Bets
- NBA Playoff Picks: Rockets vs Lakers & Spurs vs Blazers Best Bets
- MLB Betting Picks Today: Two Expert Picks for Tuesday’s Slate

